at the CNIO

Tag: obesity (Page 1 of 26)

Metabolism and Cancer meeting (20-22 May 2026)

Registration for the CNIO CaixaResearch Frontiers Meeting Metabolism and Cancer: Insights from Obesity and Beyond is open until 5 May 2026.

Held at CNIO Auditoriom from 20 to 22 may 2026, the meeting will highlight key drivers stemming from unhealthy metabolism that impact cancer development. It will delve into cutting-edge topics such as advancements in adipocyte biology, uncovering the diverse roles of adipose tissue beyond fat storage and its influence on tumor metabolism. Additionally, groundbreaking research on exercise and its potential impact on cancer will be presented. The role of mitochondrial bioenergetics in metabolic regulation will be rigorously examined, offering promising avenues for cancer therapy.

Moreover, the conference will scrutinize the tumor microenvironment and metabolic changes in surrounding tissues, alongside immune modulation,
particularly in the context of obesity. Cachexia, a complex syndrome involving muscle wasting and its relationship with cancer, will also be a focal point.

Attack of the kinases: JNK signaling in metabolism

Iara Fernández-González, Jane Jose Vattathara, Roger J. Davis, Guadalupe Sabio & Miguel López.

The global rise in obesity has become a major health concern, in part due to the easy availability and consumption of high-calorie foods together with an increasingly sedentary lifestyle.

More than a mere consequence of excess fat accumulation, obesity is now considered a complex health issue involving disrupted balance in how the body manages energy, primarily due to miscommunication between brain regions, such as the hypothalamus, and peripheral organs. One important aspect of this problem is how specific cell signaling pathways are disrupted by aberrant energy sensing and by oxidative stress-mediated damage and inflammation. Among these, AMP-activated protein kinase (AMPK) and c-Jun N-terminal kinase (JNK) have gained wide attention as key players that integrate nutrient-, hormone- and inflammation-related signals.

Here, we provide a comprehensive review of isoform-specific JNK functions, highlighting recent advances in the understanding of JNK1, JNK2 and JNK3 in hypothalamic circuits that govern energy balance, thermogenesis and hepatic lipid metabolism. In addition, we also highlight the evolutionary and physiological significance of these kinase isoforms. Thus, this review encompasses current knowledge and key unanswered questions regarding the role of JNK in central and peripheral metabolic regulation.

Los nuevos fármacos contra la obesidad pueden disminuir la incidencia de cáncer de hígado

La científica Guadalupe Sabio lidera un equipo en el Centro de Investigaciones Oncológicas (CNIO) que está analizando unas proteínas diminutas que se liberan por el tejido adiposo, con el fin de encontrar marcadores que permitan predecir el cáncer de hígado y sirvan para prevenir y tratar mejor este tipo de cáncer, uno de los de peor pronóstico, dado que suele dar señales cuando está en estado avanzado y las terapias existentes no siempre son eficaces.

Guadalupe Sabio, directora de un grupo de investigación en el CNIO que estudia la relación entre obesidad y cáncer de hígado.
« Older posts

© 2026 Sabio lab

Theme by ¡Cuánta Cienia!Up ↑